On September 1, 2021 Ziopharm Oncology, Inc. ("Ziopharm" or the "Company") (Nasdaq: ZIOP), reported that Kevin S. Boyle, Sr., Chief Executive Officer of Ziopharm, is scheduled to participate in five upcoming virtual investor conferences (Press release, Ziopharm, SEP 1, 2021, View Source [SID1234587093]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Wells Fargo Virtual Healthcare Conference
Date: September 9, 2021
Presentation Time: 10:00 am EDT

Morgan Stanley 19th Annual Global Healthcare Conference
Date: September 10, 2021
No presentation – management available for one-on-one meetings

H.C. Wainwright 23rd Annual Global Investment Conference
Date: September 13, 2021
Time: 7:00 am EDT (access to on demand webcast begins)

Lake Street 5th Annual Best Ideas Growth Conference
Date: September 15, 2021
No presentation – management available for one-on-one meetings

2021 Cantor Virtual Global Healthcare Conference
Date: September 28, 2021
Presentation Time: 3:20 pm EDT

"As one of my initial priorities as CEO, I seek to meet with our existing shareholders and hearing their perspectives," said Mr. Boyle. "I also welcome the opportunity to introduce Ziopharm’s cutting-edge TCR science to potential new investors."

To access the webcast presentations, or the subsequent archived recordings, please see the links above or visit the "Investors" section of the Ziopharm website at www.ziopharm.com.